Earnings Feed
Start Free
Home/Filings/4/0001209191-15-040812
4//SEC Filing

HYPERION THERAPEUTICS INC 4

Accession 0001209191-15-040812

CIK 0001386858operating
View on SEC.govCompany Profile

Filed

May 7, 8:00 PM ET

Accepted

May 8, 8:00 PM ET

Size

23.4 KB

Accession

0001209191-15-040812

Insider Transaction Report

Form 4
Period: 2015-05-07
HYPERION THERAPEUTICS INCHPTX
Scharschmidt Bruce Frederick
SVP & Chief Medical Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2015-05-07$46.00/sh−18,050$830,300→ 0 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−46,000$2,116,000→ 0 total
    Exercise: $24.26Exp: 2023-04-14→ Common Stock (46,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−24,000$1,104,000→ 0 total
    Exercise: $25.97Exp: 2025-02-09→ Common Stock (24,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07−27→ 0 total
    Exercise: $327.95Exp: 2018-04-21→ Common Stock (27 underlying)
  • Disposition from Tender

    Common Stock

    2015-05-07$46.00/sh−97,471$4,483,666→ 0 total
  • Disposition from Tender

    Common Stock

    2015-05-07$46.00/sh−24,448$1,124,608→ 0 total(indirect: By Trust)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−25,227$1,160,442→ 0 total
    Exercise: $7.31Exp: 2022-04-15→ Common Stock (25,227 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−32,000$1,472,000→ 0 total
    Exercise: $26.74Exp: 2024-03-10→ Common Stock (32,000 underlying)
  • Disposition to Issuer

    Common Stock

    2015-05-07$46.00/sh−6,975$320,850→ 0 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07−191→ 0 total
    Exercise: $327.95Exp: 2018-03-31→ Common Stock (191 underlying)
Footnotes (5)
  • [F1]Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer.
  • [F2]Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger").
  • [F3]Shares that are being acquired by Horizon in the Merger.
  • [F4]Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.
  • [F5]Options to acquire shares of issuer common stock that will be cancelled for no consideration in connection with the Merger.

Documents

1 file

Issuer

HYPERION THERAPEUTICS INC

CIK 0001386858

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001386858

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 8:00 PM ET
Size
23.4 KB
View on SEC.gov